A new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug, new research shows. The drug, an enzyme called adenosine deaminase, or ADA, ultimately may be able to activate the immune system against HIV and to help the immune system ‘remember’ the virus to prevent or quickly eliminate future infection.